Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Advances in the Management of Ulcerative Colitis (UC)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology USA
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
HER2 Expression in Urothelial Carcinoma (UC)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Title
Grant Type
Focus Area
Country
Application Due Date
Promote Understanding of Respiratory Infections (Streptococcus pneumoniae, Influenza virus, RSV, GBS, SARS-Cov-2)
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Increasing the Awareness of the Importance of Vaccination during Pregnancy
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Understanding Alopecia Areata for Dermatologists, Pediatric Dermatologists, and Advanced Practice Providers
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Capacity Building for Antimicrobial Stewardship
Release Date:
Review Process: Pfizer Internal
Education Hospital Japan
Implementation of Systemic Treatment Approaches in Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology China
Oncology Capacity Building in Sub-Saharan Africa (including CABO VERDE and ESWATINI)
Release Date:
Partner: Mayo Clinic Global Bridges Oncology
Review Process: Expert Review Panel
Translation: French (link)
Translation:(link)
Quality Improvement Oncology Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Tanzania, United Republic of, Togo, Uganda, Zambia, Zimbabwe
Improving Clinical Management for Patients with Breast Cancer in China
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology China
NSCLC Cancer Precision Diagnosis and Treatment
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology China
Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism
Release Date:
Partner: BMS
Review Process: Pfizer Internal
Education Internal Medicine All
Addressing Knowledge Gaps in Aplastic Anemia
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Knowledge Gaps in Treatment of Acute COVID-19 and Management of Post-COVID Conditions in Outpatient Settings
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Digital Education to Address Patients with COVID-19 and High Risk of Complications
Release Date:
Review Process: Pfizer Internal
Education Hospital All